NCT07038369 2026-03-17A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsAtavistik Bio, IncPhase 1 Active not recruiting134 enrolled
NCT04774952 2025-04-15Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsRevolution Medicines, Inc.Phase 1 Completed58 enrolled
NCT04597411 2025-03-21Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate CancerEndocytePhase 1 Recruiting99 enrolled
NCT04249947 2025-02-17P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)Poseida Therapeutics, Inc.Phase 1 Terminated40 enrolled
NCT02578797 2023-11-09A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc StudyAragon Pharmaceuticals, Inc.Phase 1 Completed45 enrolled
NCT03634982 2022-09-01Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid TumorsRevolution Medicines, Inc.Phase 1 Unknown133 enrolled